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Objective.Todeterminetheoutcomesofandsatisfactionwiththemulti-componentinﬂatablepenileprosthesis(IPP)intheelderly
male (age >71). Methods. Using a chart review and telephone survey, we retrospectively assessed patients who underwent IPP or
combined IPP/artiﬁcial urinary sphincter (AUS) from 2004–2006. Results. We identiﬁed 56 patients that underwent IPP (48) or
IPP/AUS (8). The age range was 71–86 (mean 74.3) at the time of surgery, with a follow-up range of 0.5–2.4 years (mean 1.5). The
overall complication rate was 3.8% (2 of 56) with one device removed for infection and a second patient requiring exploration for
a postoperative hematoma. The telephone interview was conducted with 35 of 56 patients. Patients rated ease of use (a scale from
1–5,5meaningveryeasy)andoverallsatisfaction(ascaleof1–5,5meaningverysatisﬁed)atanaverageof4.1and4.3,respectively.
IPP usage varied from 0–7 times per month (mean 3.3). 32 of 35 patients (91%) said they would undergo the procedure again.
Conclusion. Our review demonstrates that the IPP is well tolerated in the elderly male population, who report a high degree of
satisfaction and ease of use with this device.
1.IntroductionandObjective
Erectile dysfunction is highly prevalent in our society and
this prevalence will increase with age. Life expectancy
continuestoincreasewithUSmennowlivinggreaterthan75
years [1].Itisestimatedthatupto70%ofmalesaged70have
erectile dysfunction. The advent of oral phosphodiesterase
type 5 inhibitors has allowed many men to regain normal
sexual function and has placed the treatment of erectile
dysfunction at the forefront of men’s health issues. When
conservativetherapyfailsorwhenpatientsarenotcandidates
for oral therapy, the multicomponent inﬂatable penile
prosthesis (IPP) remains the gold standard of treatment. The
safety and eﬃcacy of the IPP has been well documented,
but in spite of this, urologists may be reluctant to oﬀer an
IPP to older patients due to various concerns, including
thoseregardingimpaireddexterityofolderpatientsandtheir
abilitytooperateaninﬂatabledevice.Thereislittlepublished
data speciﬁcally examining results of the IPP in elderly men.
Theobjectiveofthisstudywastodeterminetheoutcomeand
satisfaction of the inﬂatable penile prosthesis in the elderly
male (age >70 years).
2. Methods
We conducted a single-center, two-phase analysis of patients
over age 70 that underwent either IPP or combined IPP/
Artiﬁcial Urinary Sphincter (AUS) from 2004 to 2006. All
patients received routine preoperative counseling regarding
risks, beneﬁts, and realistic expectations of the surgery.
Preoperative medical clearance was obtained if deemed nec-
essarybythesurgeon.AllpenileimplantswerefromtheAMS
700 series with Inhibizone and tactile pump. Our routine
is to administer intravenous cefazolin preoperatively and
perform a 10-minute surgical prep with betadine. However,
since conclusion of this study, we have modiﬁed our surgical
prep to chlorhexidine gluconate due to its recently proven
superiority to povidone-iodine for surgical site antisepsis
[2]. All implants were performed by a single experienced2 Advances in Urology
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prosthetic surgeon (LAJ). The initial phase consisted of a
retrospective chart review and data collection with regards
to patient age at implantation, type of surgery (IPP or dual
IPP/AUS implantation), length of follow-up, and compli-
cations. The second phase involved a voluntary telephone
survey conducted by a neutral party to assess ease of use and
overall satisfaction (see the Appendix).
3. Results
We identiﬁed 56 men that underwent either IPP (48) or
IPP/AUS (8). Age ranged from 71 to 86 (mean 74.3) years
of age at time of surgery. The postoperative follow-up range
was 0.5–2.4 years (mean 1.5). In this group of patients,
one device (IPP only patient) was removed for infection 8
months after implantation (infection rate 1.7%). Another
patienthadapostoperativehematomarequiringexploration,
resulting in an overall complication rate of 3.4% (2 of 56).
The telephone interview was performed on 35 of the 56
patientsforaresponserateof62%.Onepatienthaddiedand
the remaining patients were unable to be contacted resulting
in a nonresponse rate of 38% (21 of 56). No patient declined
participation. Patients rated ease of use (on a scale from
1 to 5, with 5 meaning very easy to use) at an average of
4.1 (Figure 1)w i t hd i ﬃculty inﬂating the device sited as
a particular issue impairing use. Patients also rated overall
satisfaction (on a scale from 1 to 5, with 5 meaning very
satisﬁed) at an average of 4.3 (Figure 2). 28 of 35 patients
(80%) rated their overall satisfaction 4 or 5. 32 of 35
patients (91%) rated their overall satisfaction 3 or higher.
The most common complaint was dissatisfaction with penile
length, reported by 3 of the responding patients, which is a
complaint consistent with other previously published studies
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in the urologic literature [3]. Patients reported frequency
of use of the IPP at 0–7 times per month (mean 3.3) (see
Figure 3). 32 of 35 patients (91%) said that they would
choose to undergo the procedure again. Those declining
noted poor rigidity (2) or partner dissatisfaction (1). 29 of
35 patients (83%) stated that they would recommend this
procedure to a friend.
4. Discussion
The safety and eﬃcacy of the IPP has been well documented
with long-term follow-up. Carson and associates from the
AMS 700 CX study group evaluated patient satisfaction
outcomes in 372 men [4] .T h e yf o u n dt h a ta tam e d i a n
follow-up of 47 months, 79% used their prosthesis at
least twice monthly and that 88% would recommend this
procedure to others. The mean age of their population was
57.6 years. Levine et al. reviewed 131 men with a mean age
of 56.8 years implanted with the 2-piece Ambicor inﬂatable
penile prosthesis [5]. They report an overall satisfaction rate
90% of patients and 82% of partners using the Erectile
Dysfunction Inventory of Treatment (EDITS) questionnaire.
93%oftheirpatientsand90%ofpartnerswouldrecommend
the implant to others. A prospective approach using pre-
and postoperative EDITS as well as IIEF scores was by
Mulhall and colleagues who evaluated 96 men with a mean
age of 56 years [6]. They conﬁrmed statistically signiﬁcant
improvement over baseline in both inventories at 12 months
after IPP placement.
There are additional studies that support the overall
eﬃcacy of the IPP, but there is little that examines this issue
exclusively in an elderly population. This is an important
issue considering the continual increase in life expectancy
and a sense that longevity should be accompanied by quality
of life. Due to increasing life expectancy, the population of
Americans aged 65 years or older is anticipated to double in
the next 25 years [7]. As a result, we anticipate a signiﬁcant
increase in the number of elderly men seeking penile
prosthesis implantation. Lindau et al. recently reported that
elderly couples remain sexually active even into the eighth
decade of life [8]. The mean age of patients in our study
was 74.3 years at the time of surgery and no patient younger
than 71 years old was included. Most previous studies have
examined populations with an average age in the 1950s,
though Goldstein and associates examined Mentor Alpha-1
prostheses in a population with a mean age of 61 in whomAdvances in Urology 3
89%“hadfulﬁlledexpectations”[9].O’Connoretal.recently
evaluated a group of elderly men (above age 75) who had
undergone implantation of the artiﬁcial urinary sphincter
and found overall success with satisfactory results in terms of
continence, complications, and longevity of the device [10].
In general, results in this elderly cohort are comparable
to those of younger patients. Our infection rate and overall
complication rate, 1.7% and 3.4%, were low and comparable
to others reported in the general population [11]. The previ-
ously cited paper by Levine notes a 7.6% complication rate,
though with longer follow-up of 43 months. The decreased
dexterity of elderly patients or other comorbidities such as
arthritis and neuropathy might be of concern when choosing
an IPP as opposed to a malleable implant. This is certainly
a reasonable concern, but the average score of 4.1 (scale of
1–5, 5 being easiest) for ease of use demonstrates that age
alone should not favor a malleable device over an inﬂatable
one. Patients should be honestly evaluated based on their
current functional status. Overall satisfaction was also high,
with an average score of 4.3 (5 being the most satisﬁed),
and this satisfaction was evident in the frequency of implant
use. Dissatisfaction due to subjective loss of penile length
was reported by 3 of 35 surveyed patients. The previously
referenced study by Deveci et al. evaluated penile length
alterations after penile prosthesis surgery and did not note a
negative impact on stretched penile length following surgery
in their cohort [3]. In fact, despite any evidence in penile
length alteration, >70% of men in their study had subjective
loss of penile length. We use traditional sizing and corporeal
dilation techniques at the time of IPP placement. It is
our practice to counsel the patient extensively regarding
the anticipated appearance and function of the penis after
prosthetic implant, and as a result, we ﬁnd that patients with
complaints of loss of penile length are in the minority. The
frequency of implant use ranged from 0 to 7 with a mean of
3.3 times per month, comparing favorably with the younger
group evaluated by Carson et al. where 79% of the patients
used their device for intercourse at least twice monthly. For
comparison purposes, about an equal percentage (86%) of
our older population used their IPP at least twice monthly.
Direct comparison between this group of patients and
younger groups is diﬃcult for several reasons. We used
a telephone survey which lends itself to brief encounters
and therefore involves a simple but invalidated instrument
instead of longer validated ones such as the IIEF or EDITS.
We are also keenly aware of the biases that accompany
a survey. The 38% nonresponse rate may bias the results
towards increased satisfaction and more positive results.
Furthermore, though diﬀerences in patient satisfaction and
ease of use between patients undergoing IPP compared
to those undergoing dual implant (IPP/AUS) may exist,
our limited sampling of patients undergoing dual implant
precluded us from adequately assessing for this potential
confounder. Nevertheless, we have demonstrated that even
in an elderly population, the IPP is very safe and met
with a high degree of patient satisfaction. Future evaluation
in a prospective manner with validated instruments will
further solidify this conclusion. Prospective evaluation of
the partners of these elderly men would also be a valuable
addition to the body of literature and would aid in better
counseling of elderly patients.
5. Conclusions
Implantationoftheinﬂatablepenileprosthesisshouldnotbe
avoidedinelderlymalesbasedsolelyontheageofthepatient.
Our paper demonstrates that the IPP is well tolerated in this
patient population, who report a high degree of satisfaction
and ease of use with this device.
Appendix
IPP Questionnaire
(1) Ease of use:
How would you rate the ease of use of the IPP
on a scale from 1 to 5, with 1 being very diﬃcult
to use and 5 being very easy to use.
(2) Overall satisfaction:
How would you rate your overall satisfaction
with the IPP on a scale from 1 to 5, with 1 being
very unsatisﬁed and 5 being very satisﬁed.
(3) Frequency of use:
How often would you say that you are using the
IPP on a monthly basis?
None, 1–3 times, 4–6 times, or greater than 6
times
(4) Would you recommend the IPP to a friend?
(5) Would you undergo this procedure knowing what
you know now about the IPP?
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